Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPolaryx Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 2025 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/30/2025 | Q2 2025 | N/A | -$0.01 | N/A | N/A | $0 |
| 03/31/2025 | Q1 2025 | N/A | -$0.03 | N/A | N/A | $0 |
| 12/31/2024 | Q4 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Polaryx Therapeutics Inc. Earnings: FAQ's
The conference call for Polaryx Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Polaryx Therapeutics Inc.'s latest earnings report can be read online.
Polaryx Therapeutics Inc. (:PLYX) has a recorded net income of $-30,356,000.Polaryx Therapeutics Inc. has generated $-0.16 earnings per share over the last four quarters.
Polaryx Therapeutics Inc. (:PLYX) has a price-to-earnings ratio of -109.29 and price/earnings-to-growth ratio is 11.27.